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Abstract: Two new apotirucallane triterpenoids, namely chisiamols G (1) and H (2), featuring a 21,23-lactone, together with five 
known triterpenoids, were isolated from the twigs of Chisocheton paniculatus. The structures of the new compounds were elucidated
on the basis of spectroscopic and chemical methods. 
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Introduction 
The genus Chisocheton (Meliaceae) comprising about 50 
species is mainly distributed in India and Malaysia, which is 
traditionally used to treat stomach and kidney problems,  
backache, fever, rheumatism and malaria. Chisocheton  
paniculatus is the only species growing in southern China.1 
Phytochemical studies of genus Chisocheton have led to the 
isolation of sesquiterpenoids, triterpenoids and limonoids, 
some of which showed anti-inflammatory, anti-feedant,  
anti-fungal and cytotoxic activities. Previous phytochemical 
investigation on C. paniculatus resulted mainly in the isolation 
of apotirucallane-type triterpenoids.2 In the present study, two 
new apotirucallane triterpenoids, named chisiamols G (1) and 
H (2), together with five known triterpenoids, chisiamol A 
(3),2m sapelin B (4),3 3-acetoxy-21,24R-epoxyapotirucall-14-
ene-7,23R,25-triol (5),2m chisiamol B (6),2m and 3-acetoxy-
21,23-epoxyapotirucall-14-ene-7,21R,24,25-tetrol (7)2m were 
isolated from the leaves and stems of C. paniculatus (Figure 1). 
Herein, we describe the isolation and structural elucidation of 
these new compounds. 
 
Results and Discussion 
Compound 1 was obtained as a white amorphous powder. 
Its molecular formula was determined to be C32H50O7 by 
HRESIMS m/z [M  Na]+ 569.3458 (calcd for C32H50O7Na, 
569.3454). The IR absorptions at 3448, 1720 and 1630 cm–1 
indicated the presence of hydroxyl, ester carbonyl, and double 
bond groups, respectively. The 1H NMR spectrum showed 
seven tertiary methyls at H 0.85, 0.93, 0.96, 1.09, 1.12, 1.24, 
and 1.28 (each 3H, s), one acetyl methyl at H 2.06 (3H, s), 
one olefinic proton at H 5.45, and four proton signals at H 
3.26 (d), 3.95　  (br. s), 4.664.74 (m), and 4.63 (br. s)  
attributable to the protons of oxygenated methines (Table 1). 
All the 32 carbon resonances were resolved in the 13C NMR 
spectrum, and further classified by DEPT and HSQC  
experiments as eight methyls, seven sp3 methylenes, eight sp3 

































































































Figure 1.  Chemical structures of compounds 17 
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oxygenated), two ester carbonyls (C 173.2 and 181.6), and 
one trisubstituted double bond (C 120.8 and 162.2) (Table 1). 
Careful analysis of its 1H and 13C NMR data indicated that the 
NMR data of 1 highly resembled those of the co- 
existing compound 3-acetoxy-21,23-epoxyapotirucall-14-
ene-7,21R,24,25-tetrol (7)2m except for the absence of both 
the proton and carbon signals of the hemiacetal group (C 96.5; 
H 5.29), and the presence of an additional ester carbonyl,  
suggesting that C-21 hemiacetal in 7 was oxygenated to a  
lactone group (C 181.6) in 1. To prove this speculation, an 
HMBC experiment was performed, in which, the ester carbonyl
was placed at C-21 by the correlations from H2-22 (H 2.18–
2.33) and H-20 (H 2.81–2.90) to C-21 (C 181.6). This was 
supported by 1H-1H COSY spectrum, in which, a proton  
bearing structural fragment from C-17 to C-24 as depicted in 
bold bond (Figure 2) was revealed. In addition, the key HMBC 
correlations from H-3 (H 4.63) to C-1′ (C 173.2) assigned an 
acetoxy group at C-3; the HMBC correlations of Me-30 (H 
1.12)/C-7 (C 74.4), and H-7 (H 3.95)/C-6 located a hydroxyl 
group at C-7 (Figure 2). 
In the ROESY spectrum of 1, the correlations of Me-19/H-3, 
Me-29/H-3, Me-19/Me-30, and Me-30/H-7, indicated that  
Me-19, Me-29, Me-30, H-3, and H-7 were cofacial and were 
randomly assigned to be -oriented. Subsequently, the 
ROESY correlations of H-20/H-23, and Me-18/H-20 indicated 
that they were -oriented (Figure 4). The small coupling  
constant (1.9 Hz) between H-23 and H-24 indicated that they 
were in a gauche relationship, showing that H-24 was -
oriented.4 
The structure of compound 1 was further verified by  
chemical correlation with the coexisting known compound 7. 
Both compounds 1 and 7 were treated with LiAlH4 to afford a 
common compound 8 (Figure 3),5 confirming the structural 
assignment for compound 1. The structure of 8 was assigned 
as the reduced derivative of compound 7 based on the  
spectroscopic data. In the ESIMS, the [M  Na]+ peak at m/z 
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Figure 2.  1H-1H COSY (bold lines) and key HMBC (HC) 
correlations of 1 and 2 
Table 1. 1H (400 MHz) and 13C (100 MHz) NMR data of 1 and 2 (CD3OD) 
 
position 
chisiamol G (1) chisiamol H (2) 
H C H C 
1 1.221.30, m 35.0, CH2  1.251.32, m 35.0, CH2 
1 1.331.42, m  1.361.46, m 
2 1.501.57, m 24.3, CH2  1.521.62, m 24.3, CH2 
2 1.871.99, m  1.911.98, m 
3 4.63, br. s 80.3, CH 4.62, br. s 80.3, CH
4  37.8, C   37.8, C 
5 1.972.09, m 43.6, CH  1.992.11, m 43.6, CH 
6 1.611.67, m 26.0, CH2  1.621.73, m 26.0, CH2 
6 1.721.80, m  1.761.83, m 
7 3.95, br. s 74.4, CH  3.95, br. s 74.4, CH 
8  45.7, C   45.7, C 
9 1.972.09, m 43.7, CH  1.992.11, m 43.7, CH 
10  39.3, C   39.3, C 
11 1.481.53, m 18.0, CH2  1.531.58, m 18.0, CH2 
11 1.671.73, m 1.711.77, m 
12 2.092.18, m 34.3, CH2  2.152.22, m 34.4, CH2 
13  48.5, C   48.5, C 
14  162.2, C   162.3, C 
15 5.45, d (1.7) 120.8, CH  5.46, d (2.3) 120.6, CH 
16 2.282.35, m 33.6, CH2  2.282.34, m 33.8, CH2 
16 1.992.08, m  2.042.12, m 
17 2.152.22, m 56.2, CH  2.152.22, m 56.1, CH 
18 1.09, s 20.8, CH3  1.09, s 20.7, CH3 
19 0.96, s 16.4, CH3  0.96, s 16.4, CH3 
20 2.812.90, m 41.6, CH  2.95, ddd (5.7, 8.4, 12.0) 41.6, CH 
21  181.6, C   181.0, C 
22 2.182.33, m 32.5, CH2  2.45, ddd (6.5, 8.6, 12.6) 31.7, CH2 
22 2.182.33, m  1.992.06, m 
23 4.664.74, m 79.1, CH  4.26, ddd (5.7, 7.4, 10.5) 80.6, CH 
24 3.26, d (1.9) 79.5, CH 2.86, d (8.1) 66.4, CH
25  73.9, C   59.4, C 
26 1.24, s 25.3, CH3  1.34, s 19.9, CH3 
27 1.28, s 28.5, CH3  1.34, s 25.4, CH3 
28 0.93, s 22.8, CH3  0.92, s 22.8, CH3 
29 0.85, s 28.6, CH3  0.85, s 28.6, CH3 
30 1.12, s 29.3, CH3  1.10, s 29.3, CH3 
3-OAc  173.2, C   173.2, C 
 2.06, s 21.7, CH3  2.06, s 21.7, CH3 
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at m/z 553.7 were all consistent with the molecular formula 
C30H52O6 of 8 with six hydroxyl groups. A comparison of 1H 
NMR spectra of 7 and 8 was particularly informative. The 
absence of the acetyl methyl (H 2.06 in 7) and the upfield 
shifted H-3 at H 3.33 (H 4.63 in 7) of 8 indicated the  
presence of OH-3 in 8. The remaining two hydroxyls in 8 were 
assigned to C-21 and C-23 by the chemical shifts of H2-21 at 
H 3.45 and H 3.77 (each 1H, J = 11.0 Hz) and H-23 at H 
4.08, respectively. 
Hence, the structure of 1, namely chisiamol G, was assigned 
as 3-acetoxy-7,24,25-trihydroxyl-21,23-epoxyapotirucall-
14-ene-21-one, an apotirucallane-type triterpenoid possessing 
a five-membered lactone formed between C-21 and C-23. 
Compound 2 was obtained as a white amorphous powder. 
Its molecular formula C32H48O6 was assigned by HRESIMS at 
m/z [M  Na]+ 551.3348 (calcd for C32H48O6Na, 551.3349). Its 
IR spectrum exhibited absorption bands for hydroxyl (3432 
cm–1), ester carbonyl (1724 cm–1), and double bond (1630 cm–1) 
functionalities. A comparison of the 13C NMR spectra (Table 1) 
of compounds 1 and 2 revealed that their structures were close 
related, except for that two oxygenated carbon signals at  
C 79.5 (C-24) and at C 73.9 (C-25) in 1 were significantly 
upfield shifted to C 66.4 (C-24) and C 59.4 (C-25) in 2,  
respectively, suggesting that an 24,25-epoxide ring was  
present in 2 instead of the 24,25-diol motif in 1. This was  
consistent with the fact that the molecular weight of 2 was 18 
mass units less than that of 1, and was further supported by the 
almost identical chemical shifts of C-24 and C-25 of 2  
as compared with those of 7-hydroxyl-21-acetoxy-21,23-
epoxyapotirucall-24,25-epoxide-14-ene-3-one and 3,7-di-
hydroxyl-21-acetoxy-21,23-epoxyapotirucall-24,25-epoxide-
14-ene, both of which possessing an 24,25-epoxide were  
respectively reported as compounds A and D in the literature.2a 
The structure of 2 was finally confirmed by 2D NMR spectra, 
especially HMBC (Figure 2) and ROESY (Figure 4) spectra. 
In the ROESY experiment, the correlations of Me-29/H-3, 
Me-19/Me-30, and Me-30/H-7, indicated that Me-19, Me-29, 
Me-30, H-3, and H-7 were cofacial and were randomly  
assigned to be -oriented. Furthermore, the ROESY  
correlations of H-20/H-23, and Me-18/H-20 indicated that Me-
18, H-20, and H-23 were cofacial and -oriented. The 24,25-
epoxide ring was assigned to be -directed by the ROESY 
correlations of H-22/H-23 and H-22/H-24 (Figure 4).6 The 
chemical shifts of C-24 (C 66.4) and C-25 (C 59.4), and the 
coupling constant (J23,24 = 8.1 Hz) between H-23 and H-24 
further supported the -orientation of the epoxide in 2 as  
compared with the corresponding data of the bruceajavanones 
AE.6 The structure of 2 was thus established as 3-acetoxy-
7-hydroxyl-21,23-epoxyapotirucall-24,25-epoxide-14-ene-21-
one, namely chisiamol H. 
All isolated compounds (17) were tested in an anti-
microbial assay against Helicobacter pylori-SS1 in vitro  
according to standard protocols, in which Minimum inhibitory 
concentration (MIC) > 100 g/mL was defined as inactive7, 
and metronidazole (Shanghai Henshan Pharmaceutical  
Company, Ltd. with a purity of 99%; MIC = 0.312 g/mL) 
was used as the positive control. However, none of these  
compounds showed activity (MIC > 50 g/mL). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured with a Perkin-Elmer 341 polarimeter. UV spectra 
were measured on a Shimadzu UV-2550 spectrophotometer. 
IR spectra were recorded on a Perkin-Elmer 577 spectrometer 
using KBr disks. NMR spectra were measured on a Bruker 
AM-400 spectrometer. ESIMS was carried out on a Finnigan 
LCQ-DECA instrument, and HRESIMS spectra were made on 
a Bruker Daltonics micrOTOFQII or a Waters-Micromass Q-
TOF Ultima Global electrospray mass spectrometer. All  
solvents used were of analytical grade (Shanghai Chemical 
Reagents Company, Ltd.). Different absorbents were  
employed for column chromatography: silica gel (200300 
mesh) and silica gel H (Qingdao Haiyang Chemical Co. Ltd.); 
RP-18 reversed silica gel (150200 mesh, Merck); MCI gel 
(CHP20P, 75150 ím, Mitsubishi Chemical Industries Ltd.); 
Sephadex LH-20 gel (Amersham Biosciences). Fractions were 
monitored by TLC (silica gel GF254, 0.25 mm, Merck), and 
spots were visualized by heating silica gel plates sprayed with 
10% H2SO4 in ethanol. Semipreparative HPLC was performed 



































































Figure 3.  Reduction of compounds 1 and 7 to afford 8 
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and an YMC-Pack ODS-A column (10 × 250 mm, S-5 m, 12 
nm). 
 
Plant Materal. The leaves and stems of C. paniculatus, 
were collected in Mengla County, Yunnan Province of China 
in September of 2009, and the plant was identified by  
Professor You-Kai Xu of Xishuangbanna Tropical Botanical 
Garden, Chinese Academy of Sciences. A voucher specimen 
(accession number CS-2009-2Y) has been deposited in the 
Shanghai Institute of Materia Medica, Chinese Academy of 
Sciences. 
 
Extraction and Isolation. Dried leaves and stems of C. 
 paniculatus (6 kg) were extracted by 95% EtOH at room  
temperature. The crude extract (70 g) was dissolved in H2O 
(500 mL) and then extracted with EtOAc (200 mL × 3). The 
EtOAc extract (24 g) was subjected to an MCI column 
(75150 m, 8  30 cm, MeOH/H2O, 50:50 to 90:10, v/v) to 
give fractions EK. Fraction I (1.80 g) was chromatographed 
on a silica gel column eluted with petroleum ether/Me2CO 
(300400 mesh, 4  20 cm, 10:1 to 4:1) to yield four fractions 
(I14). Fraction I4 (193 mg) was subjected to a silica gel  
column (300400 mesh, 3  18 cm, CH2Cl2/MeOH, 150:1, 
100:1, 70:1, 50:1, 30:1, 20:1, 10:1) to give four fractions 
(I4ad). Purification of fraction I4b (30 mg) by a RP-18 silica 
gel column (150200 mesh, 3  15 cm, MeOH/H2O, 70:30 to 
80:20) gave 1 (20 mg). Fraction J (5.50 g) was chromato-
graphed on a silica gel column eluted with petroleum 
ether/Me2CO (300400 mesh, 8  20 cm, 10:1 to 6:1) to yield 
seven fractions (J17). Fraction J3 (221 mg) was submitted to 
a silica gel column (300400 mesh, 3  20 cm, CH2Cl2/MeOH, 
100:1, 80:1, 60:1) to give three fractions (J3ac). Purification 
of fraction J3a (12 mg) with Sephadex LH-20 (3  100 cm, 
EtOH) yielded 2 (3 mg). Fraction J3b (73 mg) was applied to a 
RP-18 silica gel column (150200 mesh, 3  15 cm, 
MeOH/H2O, 80:20 to 90:10) to give fractions J3b1 and J3b2. 
Fraction J3b2 (14 mg) was further purified by preparative 
HPLC (eluting with MeCN/H2O, 85:15 to 95:5, from 0 to 20 
min, 3 mL/min) afforded 3 (3 mg). Purification of fraction J3c 
(15 mg) by preparative HPLC (eluting with MeCN/H2O, 90:10 
to 95:5, from 0 to 20 min, 3 mL/min) yielded 4 (4 mg).  
Fraction J5 (358 mg) and J6 (293 mg) were subjected to a 
silica gel column (300400 mesh, 3  20 cm, petroleum ether/ 
EtOAc, 10:1, 8:1, 6:1, 4:1) to give two corresponding fractions 
J5ab and J6ab, respectively. Fraction J5a (140 mg) and J6a 
(255 mg) were applied to a silica gel column (300400 mesh, 
3  18 cm, CH2Cl2/MeOH, 100:1, 80:1, 60:1, 40:1) to give 
three corresponding fractions J5a13 and J6a13, respectively. 
Purification of fractions J5a2 (40 mg) and J6a3 (83 mg) were 
subjected to RP-18 silica gel column (150200 mesh, 3  15 
cm, MeOH/H2O, 90:10 to 100:0) to afford 5 (35 mg) and 6 (9 
mg). Fraction E (1.34 g) was chromatographed on a silica gel 
column eluted with petroleum ether/Me2CO (300400 mesh, 6 
 20 cm, 10:1 to 1:1) to yield seven fractions (E17).  
Purification of fraction E3 (40 mg) was applied to RP-18 silica 
gel column (150200 mesh, 3  15 cm, MeOH/H2O, 80:20 to 
90:10) to afford 7 (20 mg). 
 
Chisiamol G (1): White amorphous powder; [α] 23D    
– 105 (c = 0.27, MeOH);　UV (MeOH) max (log ) 202.4 (4.3) 
nm; IR (KBr) max 3448, 2939, 2871, 1765, 1720, 1630, 1458, 
1385, 1169, 1034 cm–1; 1H NMR and 13C NMR see Table 1; 
ESIMS m/z [M  Na]+ 569.4; HRESIMS m/z [M  Na]+ 
569.3458 (calcd for C32H50O7Na, 569.3454). 
 
Chisiamol H (2): White amorphous powder; [α]23D   – 69 (c = 
0.30, MeOH); UV (MeOH) max (log ) 201.6 (4.15) nm; IR 
(KBr) max 3432, 2937, 2871, 1774, 1724, 1630, 1458, 1385, 
1250, 1188, 1024, 818 cm–1; 1H NMR and 13C NMR see  
Table 1; ESIMS m/z [M  Na]+ 551.4; HRESIMS m/z [M  
Na]+ 551.3348 (calcd for C32H48O6Na, 551.3349). 
 
Reduction of Compounds 1 and 7 with LiAlH4. To a 
cooled solution (– 78 °C) of compound 1 or 7 (5.0 mg) in dry 
THF (2 mL), LiAlH4 (3 mg) was added under nitrogen 
atmosphere. After stirring at the same temperature for 2 h, the 
reaction mixture was then allowed to r.t. and kept stirring 
overnight. After workup, the reaction mixture was diluted with 
H2O (2 mL) and then extracted with EtOAc (3  5 mL). The 
combined organic phase were dried with anhydrous Na2SO4 
and concentrated in vacuo to obtain the crude product, which 
was purified by a silica gel column eluted with CH2Cl2/MeOH 
(300400 mesh, 3  12 cm, 50:1 to 10:1) to give compound 8 
(about 3.0 mg). 
Compound 8: ESIMS m/z 531.4 [M  Na]+, m/z 1039.7 [2M 
 Na]+, m/z 553.7 [M  HCOO]–; 1H NMR (400 MHz, H ppm, 
CD3OD): 5.44 (H-15, d, J = 2.6 Hz), 4.08 (H-23, t, J = 6.7), 
3.88 (H-17, t-like), 3.45, 3.77 (H-21, ABq, J = 11.0 Hz), 3.33 
(H-3, t-like), 3.12 (H-24, d, 1.5 Hz). 
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